Primary Job Title CEO Primary Organization 
Covidien
Gender Male
LinkedIn View on LinkedIn
Mr. Richard J. Meelia serves as the President of Mallinckrodt Inc. Mr. Meelia has been the Chief Executive Officer of Power Medical Interventions Inc., since September 2009. He served as the President of Infusaid, Inc. He served as the Chief Executive Officer and President of Tyco Healthcare at Kendall International Inc. Mr. Meelia served as the
Chief Executive Officer of Covidien Ltd. from January 2006 to July 1, 2011. He served as the President of Covidien Inc. from 1995 to July 1, 2011. He served as the Chief Executive Officer and President of Covidien Plc. He has been Chairman of Haemonetics Corp. since June 2011. He served as the Chairman of Covidien Plc from October 2008 to March 13, 2012. He served as Chief Executive Officer of tyco healthcare since June 2006 President of Tyco Healthcare and Specialty Product of Tyco International Ltd. since 1995. He served as Vice President of Tyco International Ltd. since June 2000. He serves as Chairman of the Board of Haeomonetics. He serves as Chairman of the Board of Apollo Endosurgery, Inc. and has been its Director since July 2012. He serves as a Director of Triangle, Inc. He serves as Associate of Kairos Partners L.P. He serves as a Director of Mallinckrodt Inc. He also serves on the Board of Governors of the Tufts-New England Medical Center and the Board of Trustees of St. Anselm College. He served as a Director of Aspect Medical Systems Inc. He served as a Director of VASAMED Inc. since June 1997 and Covidien plc since June 2007. He served as an Independent Director of Haemonetics Corp. He has a Bachelor's Degree from Saint Anselm College. Mr. Meelia earned an MBA degree from Boston College.
